
Genocea Biosciences
Get Full AccessDescription
- Genocea is harnessing the power of T cell immunity to develop life-changing vaccines and immunotherapies. While traditional immunotherapy discovery methods have largely used predictive methods to propose T cell targets, or antigens, Genocea has successfully developed ATLAS, its proprietary technology platform, to identify clinically relevant antigens of T cells based on actual human immune responses. Genocea is currently using ATLAS in immuno-oncology applications to develop neoantigen cancer vaccines, general cancer vaccines and a vaccine targeting cancers caused by Epstein-Barr Virus.
-
Headquarters:100 Acorn Park Drive , Cambridge, Massachusetts, United States
More -
Phone Number: +1 617-876-8191
-
Website: https://www.genocea.com/
-
Employees:81
-
Revenue:$100 - 250M
-
Legal Name:Genocea Biosciences
-
Genocea Biosciences's Social Media
-
Is this data correct?
-
| NAICS Code: 621511 |
Show More
Frequently Asked Questions regarding Genocea Biosciences
-
Where are Genocea Biosciences's Headquarters?
Genocea Biosciences's Headquarters are in 100 Acorn Park Drive ,Cambridge,Massachusetts,United States
-
What is Genocea Biosciences's phone number?
Genocea Biosciences's phone number is +1 617-876-8191
-
What is Genocea Biosciences's official website?
Genocea Biosciences's official website is https://www.genocea.com/
-
What is Genocea Biosciences's Revenue?
Genocea Biosciences's revenue is $100 - 250M
-
What is Genocea Biosciences's NAICS code?
Genocea Biosciences's NAICS code is 621511
-
How many employees are working in Genocea Biosciences
Genocea Biosciences has 81 employees
-
What is Genocea Biosciences's Industry?
Genocea Biosciences is in the industry of Biotechnology
-
Who is Genocea Biosciences's CEO?
Genocea Biosciences's CEO is Chip Clark